LSV Asset Management
SCLN

LSV Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

LSV Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-97,964
Closed -$960K – 1052
2017
Q1 		$960K Sell
97,964
-222,456
-69% -$2.22M ﹤0.01% 803
2016
Q4 		$3.46M Sell
320,420
-163,568
-34% -$1.64M 0.01% 625
2016
Q3 		$4.96M Sell
483,988
-737,869
-60% -$8.04M 0.01% 543
2016
Q2 		$16M Buy
1,221,857
+337,011
+38% +$4.42M 0.03% 344
2016
Q1 		$9.73M Buy
884,846
+143,213
+19% +$1.27M 0.02% 411
2015
Q4 		$6.82M Sell
741,633
-888,460
-55% -$7.44M 0.01% 454
2015
Q3 		$11.3M Sell
1,630,093
-2,985
-0.2% -$25.6K 0.03% 358
2015
Q2 		$16M Sell
1,633,078
-191,921
-11% -$1.75M 0.03% 304
2015
Q1 		$16.2M Sell
1,824,999
-7,182
-0.4% -$57.2K 0.03% 307
2014
Q4 		$16M Sell
1,832,181
-517,212
-22% -$4.19M 0.03% 307
2014
Q3 		$16.2M Sell
2,349,393
-146,094
-6% -$875K 0.04% 283
2014
Q2 		$13.1M Sell
2,495,487
-59,106
-2% -$288K 0.03% 322
2014
Q1 		$11.6M Sell
2,554,593
-76,442
-3% -$369K 0.03% 331
2013
Q4 		$13.3M Sell
2,631,035
-60,926
-2% -$293K 0.03% 311
2013
Q3 		$13.6M Sell
2,691,961
-146,704
-5% -$817K 0.04% 300
2013
Q2 		$14.1M Buy
+2,838,665
New +$13.5M 0.04% 282

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management's SCLN Position: Q2 2017 in Review

LSV Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017, closing a stake of 97,964 shares — an estimated $960K sold.

LSV Asset Management first reported a position in SCLN in Q2 2013 and held it in 16 quarters. The position peaked at $16.2M in Q3 2014. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • LSV Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • LSV Asset Management sold 97,964 Sciclone Pharmaceuticals Inc shares in Q2 2017, an estimated $960K.
  • LSV Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 16 quarters.
  • LSV Asset Management's Sciclone Pharmaceuticals Inc position peaked at $16.2M in Q3 2014.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on LSV Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.